[Ip-health] NHS sues Reckitt for £89m over Gaviscon supply - patent tricks...
Riaz K Tayob
riaz.tayob at gmail.com
Mon Apr 18 12:09:19 PDT 2011
[Meanwhile for almost a decade the industry disregarded the data on
h.pylori on ulcers, so their products could make money...]
NHS sues Reckitt for £89m over Gaviscon supply
Monday, 18 April 2011
The Health Secretary Andrew Lansley and the National Health Service are
suing the consumer-goods group Reckitt Benckiser for £89m over the
supply of Gaviscon, the company's heartburn medicine.
The case comes after Reckitt was fined £10.2m by the Office of Fair
Trading (OFT) in October for admitting abuse of its dominant position in
the supply of Gaviscon. The company admitted infringing British and
European competition law by withdrawing its profitable Gaviscon Original
Liquid from the National Health Service's prescription list after its
patent expired in 2005. The move meant that prescriptions would be
issued for Gaviscon Advance Liquid, which was protected by patent.
"Vigorous competition between firms supplying the public sector is vital
to ensure taxpayers get the best value for money," the OFT's chief
executive, John Fingleton, said when the fine was announced last year.
When contacted, Reckitt declined to comment on the Health Secretary's case.
More information about the Ip-health